| Lactose (India) Ltd | 124 Cr. | 98.8 | 231/84.3 | 27.5 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.54 Cr. | 1.85 | 4.29/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,848 Cr. | 446 | 479/192 | 100 | 24.3 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.9 Cr. | 44.3 | 88.6/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 51.3 Cr. | 35.0 | 35.0/17.0 | 122 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 59.1 Cr. | 78.5 | 119/69.7 | 16.0 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 56,712 Cr. | 2,009 | 2,286/1,275 | 22.6 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 319 Cr. | 13.1 | 19.0/10.8 | 19.1 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 18.0/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 784 Cr. | 1,660 | 1,999/635 | 27.1 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 93.8 Cr. | 18.8 | 32.0/17.0 | 25.6 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 1,035 Cr. | 352 | 449/219 | 9.24 | 133 | 0.71 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 3.87 Cr. | 18.4 | 39.0/15.2 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 8.76 Cr. | 3.52 | 8.28/2.11 | 4.98 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 489 Cr. | 503 | 504/211 | 73.8 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,130 Cr. | 949 | 1,565/944 | 37.4 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 59.3 Cr. | 0.29 | 1.12/0.24 | 3.90 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 42.7 Cr. | 16.2 | 26.3/11.4 | 20.8 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.58 Cr. | 9.48 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 161 Cr. | 450 | 859/431 | 9.10 | 596 | 0.33 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 83.0 Cr. | 83.0 | 92.5/26.1 | 157 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,093 Cr. | 1,347 | 2,452/1,315 | 43.8 | 174 | 0.79 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 19.4 Cr. | 42.6 | 88.7/36.1 | 42.3 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 13.2 Cr. | 5.28 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 16.4 Cr. | 109 | 152/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 56.7 Cr. | 104 | 114/9.41 | 39.1 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 33.0 Cr. | 43.8 | 80.0/33.0 | 53.2 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.60 Cr. | 22.0 | 25.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,080 Cr. | 523 | 1,028/512 | 25.8 | 72.4 | 0.23 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 87.3 Cr. | 20.2 | 35.9/18.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.4 Cr. | 22.5 | 43.7/17.4 | 49.6 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 89,992 Cr. | 2,180 | 2,998/2,090 | 54.0 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 245 Cr. | 425 | 524/241 | 25.1 | 123 | 1.06 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 46.7 Cr. | 32.5 | 55.4/26.7 | 72.9 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 69,647 Cr. | 1,199 | 1,365/994 | 20.4 | 603 | 0.33 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 155 Cr. | 248 | 303/159 | 147 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 808 Cr. | 80.7 | 122/74.0 | 20.9 | 32.6 | 1.86 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 39.1 Cr. | 30.0 | 46.0/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,564 Cr. | 1,657 | 1,902/919 | 60.6 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.16 Cr. | 0.63 | 1.33/0.51 | 104 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 222 Cr. | 29.0 | 60.0/26.0 | 14.2 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 5.39 Cr. | 9.21 | 22.2/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 121 Cr. | 5.14 | 6.57/2.82 | 282 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 61,349 Cr. | 28,870 | 37,000/25,260 | 40.7 | 1,888 | 1.66 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,626 Cr. | 731 | 972/557 | 27.6 | 226 | 0.67 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 190 Cr. | 66.8 | 100/31.3 | 53.0 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 5,038 Cr. | 1,519 | 1,740/752 | | 103 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 23,141 Cr. | 1,424 | 1,870/1,110 | 422 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 811 Cr. | 232 | 330/154 | 18.9 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 162 Cr. | 19.5 | 29.4/19.5 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,016 Cr. | 760 | 849/270 | 16.0 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,112 Cr. | 442 | 791/432 | 21.4 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,465 Cr. | 1,037 | 1,436/991 | 20.8 | 768 | 0.94 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,28,374 Cr. | 3,793 | 3,882/2,886 | 59.2 | 250 | 0.84 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 921 Cr. | 100 | 284/98.0 | | 41.3 | 0.49 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,332 Cr. | 14.2 | 23.5/14.1 | 21.2 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 20,358 Cr. | 532 | 1,328/518 | 59.3 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,717 Cr. | 163 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,12,086 Cr. | 1,717 | 1,910/1,547 | 35.7 | 324 | 0.93 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,485 Cr. | 556 | 734/441 | 388 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,906 Cr. | 310 | 335/175 | 35.8 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,288 Cr. | 320 | 502/265 | 40.6 | 125 | 0.16 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,317 Cr. | 209 | 260/111 | 123 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,414 Cr. | 4,085 | 6,718/4,050 | 25.5 | 340 | 2.86 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,852 Cr. | 2,325 | 2,725/1,772 | 34.6 | 335 | 0.86 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,449 Cr. | 5,680 | 6,739/4,904 | 30.8 | 373 | 2.20 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 168 Cr. | 47.6 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,700 Cr. | 4,959 | 5,993/3,701 | 32.1 | 841 | 0.71 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 124 Cr. | 101 | 220/81.0 | 12.8 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,428 Cr. | 396 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,808 Cr. | 750 | 1,998/604 | 72.9 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 19,203 Cr. | 14,952 | 19,748/10,060 | 98.1 | 1,263 | 0.08 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 427 Cr. | 19.1 | 41.4/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 16,050 Cr. | 896 | 1,420/660 | 10.4 | 483 | 0.67 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,222 Cr. | 40.6 | 80.7/38.4 | 29.4 | 21.8 | 0.48 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,069 Cr. | 178 | 308/162 | 23.0 | 59.3 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 39.6 Cr. | 25.0 | 130/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 267 Cr. | 74.9 | 167/72.2 | 131 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 95,074 Cr. | 2,081 | 2,403/1,774 | 21.9 | 430 | 0.57 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 945 Cr. | 472 | 872/464 | 11.8 | 357 | 0.37 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 58,466 Cr. | 1,083 | 1,093/501 | 85.7 | 91.1 | 0.11 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,105 Cr. | 1,065 | 1,235/596 | 22.5 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 149 Cr. | 69.2 | 114/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 691 Cr. | 143 | 219/123 | 39.3 | 104 | 2.11 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 599 Cr. | 342 | 500/265 | 21.7 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 16,754 Cr. | 1,052 | 1,250/802 | 33.7 | 414 | 0.47 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,041 Cr. | 1,790 | 1,918/1,303 | 39.0 | 243 | 0.85 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,286 Cr. | 192 | 302/191 | 29.4 | 38.0 | 1.29 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,370 Cr. | 1,434 | 1,758/1,168 | 36.7 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,381 Cr. | 81.1 | 127/57.5 | 20.5 | 59.7 | 0.97 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 734 Cr. | 89.9 | 124/67.2 | 24.7 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,065 Cr. | 224 | 350/190 | | 106 | 0.09 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,801 Cr. | 227 | 457/217 | 277 | 96.9 | 0.61 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,343 Cr. | 1,579 | 2,496/1,243 | 30.6 | 397 | 0.44 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,418 Cr. | 341 | 498/285 | 63.0 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 14,696 Cr. | 606 | 627/412 | 28.8 | 164 | 0.24 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 56,722 Cr. | 2,010 | 2,286/1,275 | 22.5 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 41,886 Cr. | 2,472 | 3,516/1,921 | 43.9 | 101 | 1.69 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,200 Cr. | 1,651 | 2,131/1,200 | 23.5 | 610 | 1.07 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,599 Cr. | 405 | 528/359 | 29.3 | 149 | 1.25 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 20,775 Cr. | 1,525 | 1,910/1,097 | 49.9 | 227 | 0.48 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,05,794 Cr. | 1,268 | 1,406/1,020 | 18.3 | 432 | 0.63 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,927 Cr. | 250 | 322/178 | 26.2 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,20,899 Cr. | 1,497 | 1,673/1,310 | 22.2 | 408 | 0.86 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,395 Cr. | 1,894 | 2,626/1,551 | 24.5 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 242 Cr. | 82.2 | 203/82.0 | 17.4 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,729 Cr. | 163 | 191/105 | 15.8 | 107 | 0.29 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 53.7 Cr. | 33.0 | 63.1/32.5 | 18.8 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 52,563 Cr. | 393 | 425/291 | 111 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,525 Cr. | 1,511 | 2,030/1,430 | 33.7 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 115 Cr. | 72.2 | 132/67.2 | 16.8 | 49.2 | 1.66 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 366 Cr. | 155 | 205/67.8 | 34.6 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,533 Cr. | 9,044 | 10,691/6,301 | 97.5 | 320 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,958 Cr. | 675 | 843/544 | 34.5 | 118 | 0.68 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 160 Cr. | 76.2 | 137/73.6 | 8.51 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 65,821 Cr. | 5,505 | 5,868/4,492 | 28.0 | 1,116 | 0.82 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 16,518 Cr. | 840 | 1,124/725 | 26.0 | 271 | 1.31 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 420 Cr. | 740 | 1,412/736 | | 690 | 0.68 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 33,620 Cr. | 2,690 | 3,094/2,022 | 34.5 | 345 | 1.04 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,238 Cr. | 289 | 367/258 | 22.0 | 133 | 1.80 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,785 Cr. | 414 | 575/312 | 19.9 | 147 | 0.24 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,015.30 Cr | 1,145.49 | | 51.94 | 202.18 | 0.35% | 16.29% | 15.20% | 6.10 |